{"url_path":"/sec/tdoc/8-k/2026-05-21/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1477449/0001477449-26-000030-index.html","accession_number":"0001477449-26-000030","cik":"0001477449","ticker":"TDOC","issuer_name":"Teladoc Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477449/0001477449-26-000030-index.html","primary_entity_key":"0001477449","primary_entity_name":"Teladoc Health, Inc."},"word_count":374,"has_tables":true,"body_markdown":"Item 5.07    Submission of Matters to a Vote of Security Holders.\n\nThe 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Teladoc Health, Inc. (the “Company”) was held on May 21, 2026. The Company previously filed with the Securities and Exchange Commission a definitive proxy statement and related materials pertaining to the Annual Meeting, which describe in detail each of the three proposals submitted to stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below.\n\nProposal 1 — Election of Directors\n\nThe stockholders of the Company elected each of the following director nominees proposed by the Company’s Board of Directors to serve until the 2027 Annual Meeting of Stockholders of the Company and until their respective successors have been duly elected and qualified. The voting results for each director nominee are set forth below.\n\nName\n\nFor\n\nAgainst\n\nAbstentions\n\nBroker Non-Votes\n\nCharles Divita, III\n\n76,534,562\n\n4,688,083\n\n62,996\n\n43,207,208\n\nSandra L. Fenwick\n\n74,876,294\n\n5,374,184\n\n1,035,163\n\n43,207,208\n\nCatherine A. Jacobson\n\n73,823,862\n\n6,428,082\n\n1,033,697\n\n43,207,208\n\nKenneth H. Paulus\n\n74,670,036\n\n6,524,629\n\n90,976\n\n43,207,208\n\nSusan R. Salka\n\n76,279,272\n\n4,840,123\n\n166,246\n\n43,207,208\n\nDavid L. Shedlarz\n\n74,640,078\n\n5,608,770\n\n1,036,793\n\n43,207,208\n\nMark Douglas Smith, M.D., MBA\n\n78,213,920\n\n2,011,677\n\n1,060,044\n\n43,207,208\n\nMichael S. Smith\n\n76,313,738\n\n4,883,881\n\n88,022\n\n43,207,208\n\nDavid B. Snow, Jr.\n\n67,368,308\n\n12,899,237\n\n1,018,096\n\n43,207,208\n\nProposal 2 — Advisory Vote Approving the Compensation of the Company’s Named Executive Officers\n\nThe stockholders of the Company approved, on an advisory basis, the compensation paid to the Company’s named executive officers. The voting results are set forth below.\n\nFor\n\nAgainst\n\nAbstentions\n\nBroker Non-Votes\n\n71,154,268\n\n8,973,257\n\n1,158,116\n\n43,207,208\n\nProposal 3 — Ratifying the Appointment of the Independent Registered Public Accounting Firm\n\nThe stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results are set forth below.\n\nFor\n\nAgainst\n\nAbstentions\n\nBroker Non-Votes\n\n122,580,992\n\n1,195,800\n\n716,057\n\nN/A\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 21, 2026\n\nTeladoc Health, Inc.\n\nBy:\n\n/s/ Adam C. Vandervoort\n\nName:\n\nAdam C. Vandervoort\n\nTitle:\n\nChief Legal Officer and Secretary"}